Your browser doesn't support javascript.
loading
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta.
Ulrich, Lorenz; Halwe, Nico Joel; Taddeo, Adriano; Ebert, Nadine; Schön, Jacob; Devisme, Christelle; Trüeb, Bettina Salome; Hoffmann, Bernd; Wider, Manon; Fan, Xiaoyu; Bekliz, Meriem; Essaidi-Laziosi, Manel; Schmidt, Marie Luisa; Niemeyer, Daniela; Corman, Victor Max; Kraft, Anna; Godel, Aurélie; Laloli, Laura; Kelly, Jenna N; Calderon, Brenda M; Breithaupt, Angele; Wylezich, Claudia; Berenguer Veiga, Inês; Gultom, Mitra; Osman, Sarah; Zhou, Bin; Adea, Kenneth; Meyer, Benjamin; Eberhardt, Christiane S; Thomann, Lisa; Gsell, Monika; Labroussaa, Fabien; Jores, Jörg; Summerfield, Artur; Drosten, Christian; Eckerle, Isabella Anne; Wentworth, David E; Dijkman, Ronald; Hoffmann, Donata; Thiel, Volker; Beer, Martin; Benarafa, Charaf.
Afiliação
  • Ulrich L; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
  • Halwe NJ; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
  • Taddeo A; Institute of Virology and Immunology, Mittelhäusern, Switzerland.
  • Ebert N; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Schön J; Institute of Virology and Immunology, Mittelhäusern, Switzerland.
  • Devisme C; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Trüeb BS; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
  • Hoffmann B; Institute of Virology and Immunology, Mittelhäusern, Switzerland.
  • Wider M; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Fan X; Institute of Virology and Immunology, Mittelhäusern, Switzerland.
  • Bekliz M; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Essaidi-Laziosi M; Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Schmidt ML; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
  • Niemeyer D; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Corman VM; CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kraft A; Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Godel A; Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Laloli L; Charité-Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany.
  • Kelly JN; Charité-Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany.
  • Calderon BM; German Centre for Infection Research (DZIF), Berlin, Germany.
  • Breithaupt A; Charité-Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany.
  • Wylezich C; German Centre for Infection Research (DZIF), Berlin, Germany.
  • Berenguer Veiga I; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
  • Gultom M; Institute of Virology and Immunology, Mittelhäusern, Switzerland.
  • Osman S; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Zhou B; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Adea K; Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.
  • Meyer B; Institute of Virology and Immunology, Mittelhäusern, Switzerland.
  • Eberhardt CS; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Thomann L; CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Gsell M; Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
  • Labroussaa F; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
  • Jores J; Institute of Virology and Immunology, Mittelhäusern, Switzerland.
  • Summerfield A; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Drosten C; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Eckerle IA; Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.
  • Wentworth DE; CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Dijkman R; CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Hoffmann D; Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Thiel V; Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Beer M; Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Benarafa C; Division of General Paediatrics, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Nature ; 602(7896): 307-313, 2022 02.
Article em En | MEDLINE | ID: mdl-34937050
Emerging variants of concern (VOCs) are driving the COVID-19 pandemic1,2. Experimental assessments of replication and transmission of major VOCs and progenitors are needed to understand the mechanisms of replication and transmission of VOCs3. Here we show that the spike protein (S) from Alpha (also known as B.1.1.7) and Beta (B.1.351) VOCs had a greater affinity towards the human angiotensin-converting enzyme 2 (ACE2) receptor than that of the progenitor variant S(D614G) in vitro. Progenitor variant virus expressing S(D614G) (wt-S614G) and the Alpha variant showed similar replication kinetics in human nasal airway epithelial cultures, whereas the Beta variant was outcompeted by both. In vivo, competition experiments showed a clear fitness advantage of Alpha over wt-S614G in ferrets and two mouse models-the substitutions in S were major drivers of the fitness advantage. In hamsters, which support high viral replication levels, Alpha and wt-S614G showed similar fitness. By contrast, Beta was outcompeted by Alpha and wt-S614G in hamsters and in mice expressing human ACE2. Our study highlights the importance of using multiple models to characterize fitness of VOCs and demonstrates that Alpha is adapted for replication in the upper respiratory tract and shows enhanced transmission in vivo in restrictive models, whereas Beta does not overcome Alpha or wt-S614G in naive animals.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Replicação Viral / SARS-CoV-2 / COVID-19 / Mutação Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Replicação Viral / SARS-CoV-2 / COVID-19 / Mutação Idioma: En Ano de publicação: 2022 Tipo de documento: Article